[Side effects of triptans].
Igarashi
Hisaka
H
Health Support & Promotion Center, Minamitama Plant Fujitsu Ltd., 1405 Omaru, Inagi-shi, Tokyo 206-0803, Japan.
D002490:Central Nervous System / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D006801:Humans; D007211:Indoles / Q000009:adverse effects; D008881:Migraine Disorders / Q000188:drug therapy*; D009325:Nausea / Q000139:chemically induced; D023303:Oxazolidinones / Q000009:adverse effects; D011759:Pyrrolidines / Q000009:adverse effects; D044346:Receptor, Serotonin, 5-HT1D; D017366:Serotonin Receptor Agonists / Q000008:administration & dosage / Q000009:adverse effects*; D012894:Sleep Stages / Q000187:drug effects; D018170:Sumatriptan / Q000009:adverse effects; D014230:Triazoles / Q000009:adverse effects; D014363:Tryptamines; D014839:Vomiting / Q000139:chemically induced
D007211:Indoles; D023303:Oxazolidinones; D011759:Pyrrolidines; D044346:Receptor, Serotonin, 5-HT1D; D017366:Serotonin Receptor Agonists; D014230:Triazoles; D014363:Tryptamines; C115647:eletriptan; C089750:zolmitriptan; C093622:rizatriptan; D018170:Sumatriptan